EUVIMEDEUVIMED entdecken
Crossref

Curcumin nicotinate increases LDL cholesterol uptake in hepatocytes through IDOL/LDL-R pathway regulation

Ying Huang, Fang-Yuan Liu, Jia-Tao Yang, Qian Zhao, Mei-Qi Zhu, Jing Wang, Shi-Yin Long, Qin-Hui Tuo, Cai-Ping Zhang, Li-Mei Lin, Duan-Fang Liao

European Journal of Pharmacology · 2024

DOI: 10.1016/j.ejphar.2024.176352 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmacology, 2024. Verfasst von Ying Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Quality Evaluation of Bulk Herbs of Hunan Province, Hunan University of Chinese Med-icine, Changsha, 410208, Hunan, China; Shenzhe…. Hauptthemen laut MEDLINE: Proprotein Convertase 9, Curcumin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province, Changsha Science and Technology Project, Science and Technology Program of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Curcumin nicotinate (Curtn), derived from curcumin and niacin, reduces serum LDL-C levels, partly due to its influence on PCSK9. This study investigates IDOL's role in Curtn's lipid-lowering effects. OBJECTIVE: To elucidate Curtn's regulation of the IDOL/LDLR pathway and potential molecular mechanisms in hepatocytes. METHODS: Differential metabolites in Curtn-treated HepG2 cells were identified via LC-MS. Molecular docking assessed Curtn's affinity with IDOL. Cholesterol content and LDLR expression effects were studied in high-fat diet Wistar rats. In vitro evaluations determined Curtn's influence on IDOL overexpression's LDL-C uptake and LDLR expression in hepatocytes. RESULTS: Lipids were the main differential metabolites in Curtn-treated HepG2 cells. Docking showed Curtn's higher affinity to IDOL's FERM domain compared to curcumin, suggesting potential competitive inhibition of IDOL's binding to LDLR. Curtn decreased liver cholesterol in Wistar rats and elevated LDLR expression. During in vitro experiments, Curtn significantly enhanced the effects of IDOL overexpression in HepG2 cells, leading to increased LDL-C uptake and elevated expression of LDL receptors. CONCLUSION: Curtn modulates the IDOL/LDLR pathway, enhancing LDL cholesterol uptake in hepatocytes. Combined with its PCSK9 influence, Curtn emerges as a potential hyperlipidemia therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proprotein Convertase 9CurcuminRatsAnimalsCholesterol, LDLRats, WistarMolecular Docking SimulationUbiquitin-Protein LigasesHepatocytesReceptors, LDLCholesterolLipoproteins, LDLNiacin

Stichwörter der Autor:innen

Curcumin nicotinateHyperlipidemiaIDOLLow-density lipoprotein receptorRosuvastatin

Substanzen

PCSK9 protein, humanProprotein Convertase 9Cholesterol, LDLcurcumin nicotinateCurcuminUbiquitin-Protein LigasesReceptors, LDLCholesterolLipoproteins, LDLPCSK9 protein, rat

Autor:innen und Institutionen

  • Key Laboratory for Quality Evaluation of Bulk Herbs of Hunan Province, Hunan University of Chinese Med-icine, Changsha, 410208, Hunan, China; Shenzhen Samii Medical Center, Shenzhen, 518118, Guangdong, China. Electronic…
  • Department of Biochemistry & Molecular Biology, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China. Electronic address: liufangyuan1126@163.com.
  • Department of Biochemistry & Molecular Biology, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China. Electronic address: 765614982@qq.com.
  • Department of Biochemistry & Molecular Biology, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China. Electronic address: 1591998771@qq.com.
  • Department of Biochemistry & Molecular Biology, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China. Electronic address: zhumeiqi0207@163.com.
  • Department of Biochemistry & Molecular Biology, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China. Electronic address: wwjj006@126.com.

Förderung

  • Natural Science Foundation of Hunan Province
  • Changsha Science and Technology Project
  • Science and Technology Program of Hunan Province

Zitieren

APA

Huang, Y., Liu, F. Y., Yang, J. T., Zhao, Q., Zhu, M. Q., Wang, J., Long, S. Y., Tuo, Q. H., Zhang, C. P., Lin, L. M., & Liao, D. F. (2024). Curcumin nicotinate increases LDL cholesterol uptake in hepatocytes through IDOL/LDL-R pathway regulation. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2024.176352

Vancouver

Huang Y, Liu FY, Yang JT, Zhao Q, Zhu MQ, Wang J, et al. Curcumin nicotinate increases LDL cholesterol uptake in hepatocytes through IDOL/LDL-R pathway regulation. European Journal of Pharmacology. 2024. doi:10.1016/j.ejphar.2024.176352

BibTeX
@article{Huang2024,
  author = {Huang, Ying and Liu, Fang-Yuan and Yang, Jia-Tao and Zhao, Qian and Zhu, Mei-Qi and Wang, Jing and Long, Shi-Yin and Tuo, Qin-Hui and Zhang, Cai-Ping and Lin, Li-Mei and Liao, Duan-Fang},
  title = {Curcumin nicotinate increases LDL cholesterol uptake in hepatocytes through IDOL/LDL-R pathway regulation},
  journal = {European Journal of Pharmacology},
  year = {2024},
  doi = {10.1016/j.ejphar.2024.176352}
}
Kostenlos starten →